# Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.

> **NCT07064005** · PHASE1 · RECRUITING · sponsor: **Pravat Mandal** · enrollment: 12 (estimated)

## Conditions studied

- Parkinsons Disease (PD)

## Interventions

- **DRUG:** Gamma- glutamylcysteine

## Key facts

- **NCT ID:** NCT07064005
- **Lead sponsor:** Pravat Mandal
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-23
- **Primary completion:** 2027-09
- **Final completion:** 2027-11-27
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07064005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07064005, "Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07064005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*